Published in J Ovarian Res on February 26, 2010
Extracellular matrix proteins and tumor angiogenesis. J Oncol (2010) 0.97
Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity. Gynecol Oncol (2012) 0.86
The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanisms. Cell Adh Migr (2013) 0.84
BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation. Clin Exp Metastasis (2012) 0.84
Exosomes mediated pentose phosphate pathway in ovarian cancer metastasis: a proteomics analysis. Int J Clin Exp Pathol (2015) 0.80
Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth. Cancer Lett (2015) 0.79
Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis. Mol Ther Oncolytics (2015) 0.78
Serum regulation of Id1 expression by a BMP pathway and BMP responsive element. Biochim Biophys Acta (2013) 0.76
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol (2000) 15.78
Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol (2003) 11.12
Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nat Genet (2001) 6.36
The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci (2003) 6.24
Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev (2001) 5.09
The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci U S A (2003) 4.41
Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell (2004) 4.34
MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell (1996) 3.87
Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer (2005) 3.20
Signal transduction of bone morphogenetic protein receptors. Cell Signal (2004) 3.11
Smads as transcriptional co-modulators. Curr Opin Cell Biol (2000) 2.92
Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J (2008) 2.82
Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J Cell Biol (2003) 2.51
From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family. Nat Rev Genet (2003) 2.26
Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer. Mol Ther (2004) 2.17
Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol Oncol (2005) 2.09
E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci U S A (1999) 2.05
Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol Cell Biol (2006) 1.99
Epithelial-mesenchymal interconversions in normal ovarian surface epithelium and ovarian carcinomas: an exception to the norm. J Cell Physiol (2007) 1.97
Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res (2004) 1.95
Multicellular spheroids in ovarian cancer metastases: Biology and pathology. Gynecol Oncol (2009) 1.82
Activation of LIMK1 by binding to the BMP receptor, BMPRII, regulates BMP-dependent dendritogenesis. EMBO J (2004) 1.70
Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am J Pathol (2001) 1.69
Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol (1999) 1.64
CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol (1999) 1.60
Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc (2006) 1.56
BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis (2007) 1.45
{beta}3-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer. Am J Pathol (2009) 1.37
Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer. Gynecol Oncol (1995) 1.35
Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol (2002) 1.34
Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene (2006) 1.31
Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene (2004) 1.27
Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. Cancer Res (2003) 1.21
Alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation. J Bone Miner Res (2004) 1.18
BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells. Oncogene (2004) 1.15
Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood (2001) 1.15
An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium. Int J Cancer (2000) 1.15
BMP-2 signaling in ovarian cancer and its association with poor prognosis. J Ovarian Res (2009) 1.11
Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells. Oncogene (2004) 1.07
Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood (2000) 1.04
Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues. Cancer Res (2000) 1.03
Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis. Cancer (2002) 1.02
Ovarian cancer cell proliferation and motility is induced by engagement of integrin alpha(v)beta3/Vitronectin interaction. Biol Chem (2003) 1.01
Immunolocalization and messenger RNA expression of bone morphogenetic protein-6 in human benign and malignant prostatic tissue. Cancer Res (1997) 1.01
Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res (1997) 1.01
Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies. Br J Cancer (1998) 0.99
BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells. Am J Physiol Lung Cell Mol Physiol (2003) 0.94
Mechanism of BMP-2 stimulated adhesion of osteoblastic cells to titanium alloy. Biol Cell (1999) 0.93
Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members. Oncogene (2001) 0.92
Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells. J Biol Chem (2001) 0.90
Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours. Br J Cancer (1996) 0.90
Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior. Am J Pathol (2004) 0.88
Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology (2003) 0.87
Enhancement of fibronectin synthesis and fibrillogenesis by BMP-4 in cultured rat osteoblast. J Bone Miner Res (2003) 0.83
Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology (2002) 2.25
Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc (2006) 1.56
BMP4 induces EMT and Rho GTPase activation in human ovarian cancer cells. Carcinogenesis (2007) 1.45
Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells. Gene (2008) 1.18
Inhibition of histone deacetylase activity by valproic acid blocks adipogenesis. J Biol Chem (2004) 1.13
Epigenetic regulation of proprotein convertase PACE4 gene expression in human ovarian cancer cells. Mol Cancer Res (2003) 0.95
TGF beta-induced Smad signaling remains intact in primary human ovarian cancer cells. Endocrinology (2002) 0.94
The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells. Biochem Biophys Res Commun (2003) 0.93
Identification of a putative autocrine bone morphogenetic protein-signaling pathway in human ovarian surface epithelium and ovarian cancer cells. Endocrinology (2003) 0.87
Valproic acid inhibits leptin secretion and reduces leptin messenger ribonucleic acid levels in adipocytes. Endocrinology (2004) 0.81
FGF-2 protects cardiomyocytes from doxorubicin damage via protein kinase C-dependent effects on efflux transporters. Cardiovasc Res (2013) 0.81
Establishment of primary cultures from ovarian tumor tissue and ascites fluid. Methods Mol Biol (2013) 0.81
Pcsk6 mutant mice exhibit progressive loss of ovarian function, altered gene expression, and formation of ovarian pathology. Reproduction (2010) 0.81
Valproic acid fails to induce polycystic ovary syndrome in female rats. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.78
Differential cellular responses induced by dorsomorphin and LDN-193189 in chemotherapy-sensitive and chemotherapy-resistant human epithelial ovarian cancer cells. Int J Cancer (2014) 0.77
Hormone Use After Nonserous Epithelial Ovarian Cancer: Overall and Disease-Free Survival. Obstet Gynecol (2016) 0.75
Analysis of epigenetic alterations to proprotein convertase genes in disease. Methods Mol Biol (2011) 0.75
Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer: Manitoba Ovarian Cancer Outcomes (MOCO) Study Group. Int J Gynecol Cancer (2017) 0.75
Corrigendum: Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc (2015) 0.75